Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

Nature medicine·2026
Same author

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Alimentary pharmacology & therapeutics·2026
Same author

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

Nature medicine·2026
Same author

Deletion of endothelial SOX9 reverses aging-induced cardiac dysfunction.

Cardiovascular research·2026
Same author

Elucidating the Pathogenic Role of Helicobacter pylori Infection in Hematologic Disorders: Mechanistic Insights and Future Perspectives.

Helicobacter·2026
Same author

CCR2<sup>+</sup> Neutrophils Exhibit a Proinflammatory Phenotype and Contribute to Plaque Vulnerability.

Arteriosclerosis, thrombosis, and vascular biology·2026

Related Experiment Video

Updated: Jul 5, 2025

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.3K

[Brain metastases].

Christian Schulz1, Martin Proescholdt2, Nils Ole Schmidt2

  • 1Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Deutschland.

Pneumologie (Stuttgart, Germany)
|January 24, 2024
PubMed
Summary
This summary is machine-generated.

Brain metastases occur in over 30% of lung cancer patients. Advanced therapies now overcome the blood-brain barrier, improving prognosis through multidisciplinary, personalized treatment strategies.

More Related Videos

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.7K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K

Related Experiment Videos

Last Updated: Jul 5, 2025

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.3K
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.7K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K

Area of Science:

  • Oncology
  • Neurology
  • Medical Research

Background:

  • Cerebral metastases are common in metastatic lung cancer, affecting over 30% at diagnosis and two-thirds during disease progression.
  • Historically, brain metastases were considered a poor prognostic indicator, leading to exclusion from clinical trials.
  • The blood-brain barrier is no longer an absolute impediment to treatment due to advancements in targeted molecular therapies and immuno-oncology.

Purpose of the Study:

  • To highlight the evolving treatment landscape for brain metastases in lung cancer.
  • To emphasize the importance of a multidisciplinary approach in managing these complex cases.
  • To discuss the factors influencing treatment decisions for CNS metastases.

Main Methods:

  • Review of current therapeutic strategies for cerebral metastases in lung cancer.
  • Analysis of factors guiding treatment decisions, including tumor characteristics and patient status.
  • Integration of systemic therapies with neurosurgical and radiotherapeutic interventions.

Main Results:

  • Modern systemic therapies, including targeted agents and immunotherapies, can effectively penetrate the central nervous system (CNS).
  • Treatment decisions are complex, requiring evaluation of metastasis burden, patient condition, tumor biology, and available CNS-effective therapies.
  • Combined therapeutic approaches (systemic, surgical, radiotherapeutic) are increasingly utilized.

Conclusions:

  • The management of brain metastases in lung cancer has significantly advanced, moving beyond historically unfavorable prognoses.
  • Multidisciplinary team decision-making is crucial for optimizing treatment strategies.
  • Personalized and integrated therapeutic approaches offer improved outcomes and prognosis for patients with lung cancer brain metastases.